Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes-Reference-Cited by-同舟云学术

Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes

Published:2022-05-04 Issue:3 Volume:3 Page:636-643
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Bernit Emmanuelle¹^ORCID,Romana Marc²³⁴,Alexis‐Fardini Scylia¹,Tarer Vanessa¹,Roger Pierre‐Marie⁵,Doumdo Lydia¹,Petras Eléonore¹,Charneau Corine⁶,Tressières Benoit⁷,Dessources Marie Dominique Hardy²³⁴,Etienne‐Julan Maryse¹²³⁴

Affiliation:

1. Sickle Cell Disease Unit Reference Centre for Sickle Cell Disease Thalassemia and Other Red Cell Rare Diseases CHU de la Guadeloupe Pointe‐à‐Pitre Guadeloupe France

2. Laboratoire d'Excellence du Globule Rouge (Labex GR‐Ex) PRES Sorbonne Paris France

3. Université des Antilles UMR_S1134/Inserm BIGR Pointe‐à‐Pitre Guadeloupe France

4. Université de Paris UMR_S1134 BIGR INSERM Paris France

5. Service d'infectiologie CHU de la Guadeloupe Pointe à Pitre Guadeloupe France

6. Sickle Cell Disease Unit Centre Hospitalier de la Basse‐Terre Basse‐Terre France

7. Centre d'Investigation Clinique Antilles Guyane Inserm CIC Point‐à‐Pitre Guadeloupe France

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.449

Reference27 articles.

1. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates

2. Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): A 27-year experience

3. Sickle cell disease

4. Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anaemia patients with splenic defects

5. Raised Neutrophil Phospholipase A2 Activity and Defective Priming of NADPH Oxidase and Phospholipase A2 in Sickle Cell Disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of COVID-19 in patients with sickle cell disease in French Guiana;Heliyon;2024-06

2. COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis;eClinicalMedicine;2023-12

3. Impact of COVID‐19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease;eJHaem;2023-10-02

4. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID‐19 and sickle cell disease in the United States;European Journal of Haematology;2023-07-21

5. COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism;Cureus;2023-04-06